Prescriptions for semaglutide and tirzepatide among patients with PCOS Between 2021 and 2025, 445,258 patients with PCOS had at least one medical encounter, of whom 90,206 (20.3%) received a semaglutide or tirzepatide prescription during the study period
BPC-157 can play an essential role in the functioning of the GI tract, where it can combat adverse conditions such as gastro-intestinal cramps, leaky gut, and Crohns disease [2]
GLP-1 RAs, Glucagon-like peptide-1 receptor agonists
Unlike some earlier-generation GH secretagogues, Ipamorelin was developed specifically for its selectivitydemonstrating minimal stimulatory effect on cortisol or prolactin release at therapeutic doses in preclinical models
If a mother's caloric intake becomes severely restricted due to medication-induced appetite suppression, this could theoretically affect both milk quantity and nutritional quality, potentially impacting infant nutrition
Current Research on Glutathione Supplementation As we consider the safety of glutathione supplementation, it's essential to look at the scientific evidence